Navigation Links
LX4211 for Diabetes Shown to Reduce Fasting and Post-Prandial Blood Sugar in Healthy Subjects
Date:9/13/2011

le metabolic effects in healthy subjects, together with the safety profile observed to date, suggest that LX4211 could be considered earlier in the diabetes treatment paradigm, perhaps including the potential treatment of pre-diabetes in patients with impaired glucose tolerance or impaired fasting glucose (IGT/IFG)."

About the Clinical Trial

The clinical trial was designed to assess the effect of different LX4211 dose schedules relative to meal time  in healthy subjects when taken as a single daily dose (400 mg) or a split dose (200 mg twice daily).  Subjects were randomized to LX4211 in an ordered sequence to assess the pharmacodynamic effects of different dosing times, ranging from 1 hour prior to meals to immediately prior to meals.  Pharmacodynamic effects, include urinary glucose excretion, fasting plasma glucose, insulin, PYY and GLP-1 (total and active) were assessed at multiple time points during the 12-day dosing period.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has four drug programs in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's clinical development of LX4211, including characterizations of the results of and projected timing o
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
2. Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
3. Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes
4. Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients
5. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
6. Lexicon Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual Meeting
7. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
8. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
9. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
10. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
11. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...   Direct to implant, or "one step," ... option for many women with BRCA (BReast CAncer) ... cancer risk, or with breast cancer. Traditionally, post-mastectomy ... second surgery to insert permanent implants, but immediate ... mastectomy can be a medically and cosmetically effective ...
(Date:5/23/2013)... , May 23, 2013  Net Medical Xpress Solutions, ... market, announced today the company has signed a letter ... company based in Huntsville, AL . ... in the staffing and recruitment of telemedicine physicians. Consideration ... the final agreement, which is expected by June 30, ...
(Date:5/23/2013)... , May 23, 2013 Israel ... Israel 2013 , Israel,s 1 st ... October 14 th -15 th in Tel ... most innovative city in the world by the Wall ... BrainTech Israel 2013 will showcase the latest breakthroughs ...
Breaking Medicine Technology:Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
... Taiho Pharmaceutical Co., Ltd. announced on May 31 ... the novel combination antimetabolite TAS-102 will start in June ... double-blind, placebo-controlled Phase III trial that compares TAS-102 with ... safety of TAS-102 when administered to patients with advanced ...
...  Today, at the 52nd annual New Clinical Drug Evaluation ... of Psychiatry at the University of California, Los Angeles ... presented the results from the first 6-subject cohort of ... effects of external trigeminal nerve stimulation (eTNS™) on Post-Traumatic ...
Cached Medicine Technology:Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102 2Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102 3Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 2Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 3Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 4Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 5
(Date:5/24/2013)... France: A new investigational device - the Helio System ... XT Transcatheter Heart Valve was successfully deployed in all ... its use in high-risk aortic insufficiency reported at EuroPCR ... anchor to help stabilise the SAPIEN XT valve for ... heart are captured between the transcatheter heart valve and ...
(Date:5/24/2013)... Palm Beach Gardens, FL (PRWEB) May 24, 2013 ... plastic surgeons jealous, Dr. Greg DeLange of the ... each of the hosts of KOOL 105.5 FM’s popular morning ... on the air about their experiences and their satisfaction with ... Estetica Institute, a cutting-edge facility located in Palm Beach Gardens, ...
(Date:5/24/2013)... Residents of San Diego have a new ... expert, and Certified Russian Kettlebell Instructor, Cody Bramlett has ... San Diego, California. The classes take place Monday through ... Initial sign-ups are available online and by clicking ... for years. The bootcamps being offered in San ...
(Date:5/24/2013)... DiscountHumidifiers.com, an eCommerce store specializing in economical humidification ... line of humidifiers. These tastefully designed humidifiers are ... styles to choose from. , The ... piece – yet its functionality is not easily recognized. ... an inconspicuous humidifying appliance. With the built-in aroma diffuser, ...
(Date:5/24/2013)... the first conference of its kind, Impacts World ... and decision makers from politics, business and civil ... integrated climate impact research across sectors and scales. ... World 2013 on May 27th, 1pm to 1:55pm ... , Speakers include: , Connie Hedegaard, ...
Breaking Medicine News(10 mins):Health News:Feasibility trial reports deployment of new device for TAVI in aortic insufficiency 2Health News:Dr. Greg DeLange of the Estetica Institute Recently Performed Eye Surgery on Both Members of Popular Morning Radio Team 2Health News:DiscountHumidifiers.com Announces the Launch of the New Broksonic Humidifiers to their Online Store 2
... , ALEXANDRIA, Va., Oct. 28 The same reassuring voice ... poison emergency may be the same person answering your questions ... centers are among the first responders helping America respond to ... a variety of ways. , A few examples: , ...
... microorganisms, and microbial cells found in the human gut are ... However, little is known about the ways in which ... That is why gastroenterologists at Rush University Medical Center ... U.S. Department of Defense to chart the presence of microorganisms ...
... reduce eyestrain, poor posture, study finds , WEDNESDAY, Oct. ... help reduce the level of pain linked to poor ... shouldn,t just assume that problems will be solved by ... chairs. It,s also important to make sure the furniture ...
... Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical ... announced today that the Food and Drug Administration has ... the Company,s BIOGUARD(TM) barrier gauze wound dressings as Class ... its initial market clearance on February 25, 2009, via ...
... BLOOMINGTON, Minn., Oct. 28 The Child Neurology Foundation ... Spasms Awareness Week (October 11-17) that will go towards ... of epilepsy. , "Due to its rare nature, ... as it should be," said Lawrence Brown, M.D., Associate ...
... , WEDNESDAY, Oct. 28 (HealthDay News) -- Letting children sleep ... overweight or obese, a new study suggests. , Researchers ... tended to be heavier (as measured by body mass index, ... who slept less than eight hours a night, those who ...
Cached Medicine News:Health News:American Association of Poison Control Centers: Count U.S. Poison Centers Among First Responders in H1N1 Flu Pandemic 2Health News:Gastroenterologists explore relationship between bacteria in the gut and breast cancer 2Health News:Gastroenterologists explore relationship between bacteria in the gut and breast cancer 3Health News:Takes a Pro to Make Offices Pain-Free 2Health News:FDA Issues Guidance for Derma Sciences' Exclusive Wound Dressing With pDADMAC 2Health News:FDA Issues Guidance for Derma Sciences' Exclusive Wound Dressing With pDADMAC 3Health News:FDA Issues Guidance for Derma Sciences' Exclusive Wound Dressing With pDADMAC 4Health News:Child Neurology Foundation Announces $30,000 Grant for Research Into Cause and Treatment of Infantile Spasms 2Health News:Child Neurology Foundation Announces $30,000 Grant for Research Into Cause and Treatment of Infantile Spasms 3Health News:Let Kids Sleep Late on Weekends to Fight Fat: Study 2Health News:Let Kids Sleep Late on Weekends to Fight Fat: Study 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: